These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 20496811

  • 1. [How to choose correct proton pump inhibitors to patients with GERD?].
    Bordin DS.
    Eksp Klin Gastroenterol; 2010; (2):53-8. PubMed ID: 20496811
    [Abstract] [Full Text] [Related]

  • 2. Dexlansoprazole in the treatment of esophagitis and gastroesophageal reflux disease.
    Abel C, Desilets AR, Willett K.
    Ann Pharmacother; 2010 May; 44(5):871-7. PubMed ID: 20371754
    [Abstract] [Full Text] [Related]

  • 3. Dexlansoprazole (Kapidex) for GERD and erosive esophagitis.
    Med Lett Drugs Ther; 2009 Mar 23; 51(1308):21-2. PubMed ID: 19305367
    [No Abstract] [Full Text] [Related]

  • 4. Rabeprazole: a second-generation proton pump inhibitor in the treatment of acid-related disease.
    Pallotta S, Pace F, Marelli S.
    Expert Rev Gastroenterol Hepatol; 2008 Aug 23; 2(4):509-22. PubMed ID: 19072398
    [Abstract] [Full Text] [Related]

  • 5. [Factors affecting efficacy of gastroesophageal reflux disease treatment with proton pump inhibitors].
    Ter Arkh; 2012 Aug 23; 84(2):16-21. PubMed ID: 22715656
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
    Higginbotham TW.
    Ann Pharmacother; 2010 Mar 23; 44(3):572-6. PubMed ID: 20124466
    [Abstract] [Full Text] [Related]

  • 7. Proton pump inhibitor utilization patterns in infants.
    Barron JJ, Tan H, Spalding J, Bakst AW, Singer J.
    J Pediatr Gastroenterol Nutr; 2007 Oct 23; 45(4):421-7. PubMed ID: 18030207
    [Abstract] [Full Text] [Related]

  • 8. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
    Johnson DA, Levy BH.
    Expert Opin Pharmacother; 2010 Jun 23; 11(9):1541-8. PubMed ID: 20450445
    [Abstract] [Full Text] [Related]

  • 9. Increased esophageal mucosal/submucosal blood flow in patients with gastroesophageal reflux disease: normalization by treatment with a proton pump inhibitor.
    Mine S, Iida T, Tabata T, Okada Y, Tanaka Y.
    J Gastroenterol Hepatol; 2008 Feb 23; 23(2):303-9. PubMed ID: 17725600
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pharmacokinetics of the proton pump inhibitors and psychological status in patients as factors that influence the efficiency of treatment of GERD with pantoprazole].
    Bordin DS, Masharova AA, Sil'vestrova SIu, Firsova LD, Safonova OV, Petrakov AV, Kozhurina TS, Valitova ER, Ianova OB.
    Eksp Klin Gastroenterol; 2010 Feb 23; (9):90-6. PubMed ID: 21427932
    [Abstract] [Full Text] [Related]

  • 12. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Feb 23; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
    Bordin DS, Masharova AA.
    Eksp Klin Gastroenterol; 2008 Feb 23; (5):85-90. PubMed ID: 19145922
    [No Abstract] [Full Text] [Related]

  • 18. Emerging drugs for gastroesophageal reflux disease.
    Boeckxstaens GE.
    Expert Opin Emerg Drugs; 2009 Sep 23; 14(3):481-91. PubMed ID: 19650746
    [Abstract] [Full Text] [Related]

  • 19. Proton pump inhibition. An effective, safe approach to GERD management.
    Berardi RR.
    Postgrad Med; 2001 Oct 23; Spec No():24-35. PubMed ID: 11868428
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.